Sixty Waterborne Disease Outbreaks Tied to Splash Pads From 1997 to 2022
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Dec. 4, 2024 -- Sixty waterborne disease outbreaks associated with splash pads were reported during 1997 to 2022, according to research published in the Dec. 5 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Hannah Lawinger, M.P.H., from the CDC in Atlanta, and colleagues characterize splash pad-associated waterborne disease outbreaks reported to the CDC that occurred during 1997 to 2022.
The researchers identified 60 waterborne disease outbreaks associated with splash pads that were reported during 1997 to 2022 by public health officials from 23 states and Puerto Rico. The outbreaks resulted in 10,611 cases, 152 hospitalizations, and 99 visits to the emergency department; however, there were no reports of deaths. Forty outbreaks were confirmed to be causal, in part, by Cryptosporidium; these resulted in 91 and 81 percent of cases and hospitalizations, respectively. Seventy-three percent of emergency department visits resulted from two outbreaks suspected to be caused by norovirus.
"Although splash pads can create an opportunity for pathogen transmission, particularly to young children, outbreaks associated with splash pads are preventable," the authors write. "Public health officials and the aquatics sector can use the findings in this report to promote the prevention of splash pad-associated outbreaks (e.g., recommended user behaviors) and guide the construction, operation, and management of splash pads."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-06 00:00
Read more
- Salmonella Outbreak Triggers Recall of Cucumbers in 26 States
- About 1 in 10 U.S. Adults Have High Cholesterol
- Risk for Mortality Up With Low Income in Type 2 Diabetes
- RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
- What Works Best to Help Young Vapers Quit?
- Vitamin D Supplements Could Help Lower Blood Pressure in Obese People
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions